Pharma News, 2023

New Delhi : India has seen extraordinary growth in the pharma industry and has reached from Zero to 13 per cent of the global market. This impressive growth is an outcome of a series of sound legis...

The U.S. Food and Drug Administration has classified Abbott’s recall of the FreeStyle Libre, Libre 14 day, and Libre 2 Flash continuous glucose monitoring system (CGM) readers as a Class I recall...

A sign of change is showing in the Korean diabetes treatment market, sized at 1 trillion won ($760 million). The catalyst of change is the provision of insurance benefits for the combined use of DP...

Johnson & Johnson (J&J) has said it is offering $8.9bn to resolve the tens of thousands of lawsuits it faces in North America that claim its talc-based products cause cancer. ...

Sartorius has said it will acquire Polyplus for around €2.4bn from private investors to bolster its activities supplying cell and gene therapy companies.

The companies will jointly identify molecular glue degraders against multiple therapeutic targets Merck.

The designation helps the firm accelerate the development and evaluation of CB-011.

The EUA is backed by data obtained from the multicentre Phase III PANAMO trial.

Shionogi has obtained fast track designation from the US Food and Drug Administration (FDA) for its ensitrelvir fumaric acid, an investigational oral antiviral drug for the treatment of Covid-19. ...

Pitolisant will be assessed in 200 patients with idiopathic hypersomnia, using change in excessive daytime sleepiness as the primary end point.

Investigators exercised caution when considering administration of antithrombotics or a thrombolytic agent for patients on lecanemab as cases of intracerebral hemorrhage of more than 1cm have been ...

Camber Pharmaceuticals has recalled one lot of Atovaquone oral suspension, USP 750mg/5mL because of the possible contamination with Bacillus cereus — bacteria found in soil, plants and food. ...